Sullivan Timothy Eugene - Insider Transactions
Insider Type
individual
Companies
1
Average
222,559
Total Txns
15
Long-Term
Annual Transaction Insights
Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
---|---|---|---|---|---|---|
2023 | 0 | 2 | -2 | 0.00 | 774,884.32 | -774,884.32 |
2024 | 0 | 7 | -7 | 0.00 | 1,149,181.66 | -1,149,181.66 |
2025 | 0 | 6 | -6 | 0.00 | 1,414,315.02 | -1,414,315.02 |
Total: | 0 | 15 | 10 | 0.00 | 3,338,381.00 | -3,338,381.00 |
Transactions
Company | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
27.86 USD |
32,729 Sold |
911,830 USD |
08/09/2025 | 08/09/2025 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
27.83 USD |
10,000 Sold |
278,300 USD |
08/09/2025 | 08/09/2025 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
29.52 USD |
546 Sold |
16,120 USD |
29/01/2025 | 29/01/2025 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
30.43 USD |
3,088 Sold |
93,954 USD |
22/01/2025 | 22/01/2025 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
29.96 USD |
1,730 Sold |
51,828 USD |
17/01/2025 | 17/01/2025 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
28.70 USD |
2,170 Sold |
62,284 USD |
13/01/2025 | 13/01/2025 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
58.66 USD |
4,000 Sold |
234,640 USD |
01/04/2024 | 01/04/2024 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
62.86 USD |
4,000 Sold |
251,440 USD |
01/03/2024 | 01/03/2024 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
63.95 USD |
2,000 Sold |
127,900 USD |
01/03/2024 | 01/03/2024 |
Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
67.77 USD |
1,431 Sold |
96,974 USD |
12/02/2024 | 12/02/2024 |